REQUEST A DEMO
Total
USD $0.00
Search more companies

Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港)) (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Zai Lab Limited Profile Updated: August 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Zai Lab Limited is a biopharmaceutical company engaged in bringing transformative medicines for cancer, autoimmune and infectious diseases. The main products of the company include Zejula® and Optune®. The company was founded in 2013, and headquartered in Shanghai City, China.

Headquarters
4560 Jinke Road, Bldg. 1, Fourth Floor, Pudong
Shanghai; Shanghai; Postal Code: 201210

Contact Details: Purchase the Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港)) report to view the information.

Website: http://www.zailaboratory.com

Basic Information
Total Employees:
Purchase the Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港)) report to view the information.
Outstanding Shares:
Purchase the Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港)) report to view the information.
Registered Capital:
Purchase the Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港)) report to view the information.
Financial Auditors:
Purchase the Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港)) report to view the information.
Incorporation Date:
March 28, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
9.19%
Purchase this report to view the information.
7.24%
Purchase this report to view the information.
6.86%
Purchase this report to view the information.
6.11%
Purchase this report to view the information.
5.59%
Subsidiaries
Zai Anti Infectives (Hong Kong) Limited (Hong Kong SAR, China)
Zai Anti Infectives Limited (United Kingdom)
Zai Auto Immune (Hong Kong) Limited (Hong Kong SAR, China)
Company Performance
Financial values in the chart are available after Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港)) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
15.21%
Total operating revenue
15.21%
Operating profit (EBIT)
23.76%
EBITDA
27.17%
Net Profit (Loss) for the Period
28.36%
Total assets
19.26%
Total equity
15.41%
Operating Profit Margin (ROS)
23.84%
Net Profit Margin
22.88%
Return on Equity (ROE)
9.81%
Debt to Equity Ratio
9.8%
Quick Ratio
-0.19%
Cash Ratio
-0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?